Secondary Progressive Multiple Sclerosis (SPMS)

Also known as: Secondary Progressive MS (SPMS) / Secondary Multiple Sclerosis, Progressive / Secondary Progressive MS / Secondary-progressive Multiple Sclerosis / Secondary Progressive Multiple Sclerosis / Multiple Sclerosis, Secondary Progressive

DrugDrug NameDrug Description
DB00068Interferon beta-1bA form of recombinant human interferon used to slow the progression of relapsing multiple sclerosis and to reduce the frequency of clinical symptoms.
DB01204MitoxantroneA chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis.
DrugDrug NamePhaseStatusCount
DB00279Liothyronine1Completed1
DB00166Lipoic acid1Completed1
DB00108Natalizumab1Completed1
DB00073Rituximab1Completed1
DB05767Andrographolide1 / 2Recruiting1
DB06576Baminercept1 / 2Withdrawn1
DB00594Amiloride2Completed1
DB01285Corticotropin2Active Not Recruiting1
DB01184Domperidone2Completed1
DB04573Estriol2Recruiting1
DB00472Fluoxetine2Completed1
DB05266Ibudilast2Completed1
DB00555Lamotrigine2Completed1
DB00108Natalizumab2Completed1
DB00717Norethisterone2Recruiting1
DB00740Riluzole2Completed1
DB00641Simvastatin2Completed1
DB00641Simvastatin2Recruiting1
DB00624Testosterone2Withdrawn1
DB04921Dirucotide2 / 3Completed1
DB04921Dirucotide2 / 3Terminated1
DB05259Glatiramer2 / 3Completed1
DB00073Rituximab2 / 3Completed1
DB00087Alemtuzumab3Recruiting1
DB06637Dalfampridine3Completed1
DB08908Dimethyl fumarate3Terminated1
DB04921Dirucotide3Terminated1
DB11526Masitinib3Completed1
DB01204Mitoxantrone3Terminated1
DB00108Natalizumab3Recruiting1
DB00108Natalizumab3Terminated1
DB11988Ocrelizumab3Recruiting1
DB00073Rituximab3Recruiting1
DB00641Simvastatin3Recruiting1
DB12371Siponimod3Active Not Recruiting1
DB06637Dalfampridine4Completed1
DB09150Fludeoxyglucose (18F)Not AvailableRecruiting1
DB05259GlatiramerNot AvailableNot Yet Recruiting1
DB00068Interferon beta-1bNot AvailableCompleted2
DB08880TeriflunomideNot AvailableNot Yet Recruiting1